Strategy should not only be addressed in times of crisis – a well-managed company will be constantly appraising its approach, from its business model, finances and risk management to its R&D, sales and marketing, investor relations, and communications.
Timely analysis will enable you and your company to stay ahead of the game.
As companies evolve and enter new phases of development, a clear analysis of the situation, available options and how to proceed is crucial to success. EJ Palmer Consulting can advise as you plan your company’s new strategy in a variety of settings.
- The transition to life as a listed company following an IPO
- Management and Board changes and other personnel issues
- Following M&A
- Changes in the clinical pipeline as well as in the marketed portfolio
- Drug candidate success and failure
- Consultation on your strategic options
- Financial analysis and modelling
- Competitor and market analysis
- Bespoke research
- Business plan advisory